Reversing Borderline Prediabetes With Continuous Glucose Monitors
- Feb 4
- 4 min read
Reversing Borderline Prediabetes: What Continuous Glucose Monitors Are Teaching Us
Borderline prediabetes often sits in an uncomfortable grey area. Blood markers aren’t yet “diabetic,” symptoms may be minimal, and as a result, many people delay action. But with the rise of continuous glucose monitors (CGMs), we’re now able to see—often for the first time—how daily decisions directly shape glucose control in real time.
At Epic Genetics, we’ve been working with clients who sit at varying levels of genetic risk for type 2 diabetes, using CGMs alongside targeted nutritional and lifestyle interventions. Over a three- to four-month period, some remarkably consistent patterns have emerged.

Three Clients, Three Genetic Profiles, One Clear Signal
Recently, we observed three clients with borderline prediabetic glucose responses, each carrying different genetic risk profiles for type 2 diabetes.



Client A, who had the lowest genetic risk, used berberine phytosome alone
Clients B and C, who had higher genetic risk, used berberine phytosome combined with R-stabilised alpha-lipoic acid (R-ALA)
Before intervention, Client A regularly experienced post-meal glucose spikes in the 9.5–10.0 mmol/L range. After introducing berberine phytosome, those spikes consistently dropped by around 1 mmol/L,
settling closer to 8-8.5 mmol/L.

While this improvement was meaningful, the most pronounced effects were seen in the two clients combining berberine with R-ALA. Their same post-meal glucose spikes were lower, shorter in duration, and returned to baseline more rapidly—despite their higher inherited risk.
This reinforces an important po
int: genetics load the gun, but environment pulls the trigger.


Timing Matters: Why 5–10 Minutes Made a Difference
An interesting practical insight emerged around supplement timing.
All three clients experimented with taking their supplements at different intervals before meals. Across the board, the most consistent glucose improvements occurred when supplements were taken approximately 5–10 minutes before eating.
This likely reflects the relatively fast-acting nature and half-life characteristics of both berberine phytosome and R-stabilised alpha-lipoic acid. Taken too early, the effect appeared blunted by the time food was consumed. Taken too late, the glucose rise had already begun.
CGMs made this immediately visible—something that would be almost impossible to identify using fasting glucose or quarterly blood tests alone.
Why “Breakfast” Matters (Even If You Skip It)
One of the strongest glucose patterns we consistently see occurs at the first meal of the day.
Many people say they “don’t eat breakfast,” but breakfast literally means breaking the fast. Whether that happens at 7am or 1pm, how you break your fast sets the tone for glucose handling for the rest of the day.
Common pitfalls include:
High-glycaemic fruits
Fruit juices or smoothies
Cereals, oats, toast, or pastries eaten in isolation
CGM data repeatedly shows that breaking a fast with carbohydrate-dominant foods leads to exaggerated glucose spikes and poorer glucose control for hours afterward.
In contrast, starting the day with:
Protein first
Followed by fibre-rich foods
With carbohydrates introduced later or in smaller amounts
results in flatter glucose curves and improved insulin sensitivity throughout the day. For those who prefer larger breakfasts, prioritising protein appears particularly protective.
Macros Matter — But Polyphenols Are Often Overlooked
Most dietary advice still focuses heavily on macronutrients: carbohydrates, fats, and protein. While important, CGM data suggests this is only part of the picture.
At Epic Genetics, we’ve observed recurring patterns around polyphenol intake—bioactive plant compounds that rarely receive the attention they deserve.
While polyphenols as a group are beneficial, certain subclasses appear especially relevant to metabolic health. Anthocyanins, for example—found in deeply coloured berries and plants—are strongly associated with improvements in blood pressure regulation and glucose handling.
Rather than broad advice like “eat more plants,” CGMs allow us to observe how specific foods and compounds influence glucose responses in individual clients. This level of resolution is still missing from much of mainstream nutrition guidance.
Fibre, Movement, and Glucose Disposal
Two simple interventions consistently amplify results:
Increasing fibre intake globallyFibre slows carbohydrate absorption, reduces glucose spikes, and improves insulin sensitivity—especially when combined with polyphenol-rich foods.
Light movement after mealsMany clients spend long hours seated during the workday. CGM data clearly shows exaggerated post-lunch glucose spikes on sedentary days.
Even 5–10 minutes of walking, or simply standing and moving after meals, significantly improves glucose clearance. Muscles act as powerful glucose sinks—and CGMs make this effect unmistakable.
Glucose, Epigenetics, and Biological Age
Beyond short-term glucose control, there’s a larger reason this matters.
Glucose markers—particularly fasting glucose and HbA1c—are heavily weighted in epigenetic health and longevity assessments. Chronic glucose dysregulation is one of the strongest drivers of accelerated biological ageing.
Many modern epigenetic tests incorporate glucose-related markers directly into their algorithms. For example, TruDiagnostic UK, whose epigenetic clocks are widely used in health optimisation and longevity research, includes glucose and HbA1c as important contributors across multiple biological age models.
In other words, improving glucose control doesn’t just change how you feel today—it can meaningfully influence how your biology ages over time.
What Happens After Three to Four Months?
When CGMs are combined with:
Targeted supplementation
Precise timing strategies
Smarter meal sequencing
Increased fibre and polyphenol intake
Strategic daily movement
we often see substantial improvements in longer-term markers.
In some cases, HbA1c has dropped by as much as 7 points within four months—a clinically meaningful shift achieved without pharmaceutical escalation. Crucially, these results are driven not by restriction, but by awareness and intelligent adjustment.

The Bigger Picture
Continuous glucose monitors don’t just measure glucose—they educate. They turn invisible metabolic stress into immediate feedback, allowing people to understand how their own genetics respond to real-world choices.
For those on the edge of prediabetes, this feedback loop can be the difference between progression and reversal.
At Epic Genetics, we see CGMs as a gateway technology—one that bridges genetics, nutrition, epigenetics, and long-term health. When used correctly, they transform glucose from a silent risk factor into a controllable variable.
And that changes everything.
Find out more about our Glucose Optimisation Service




Comments